| Literature DB >> 35291908 |
Shu Chen1, Shan Zhang2, Honggang Wu1, Daobao Zhang1, Guoliang You1, Jing You1, Niandong Zheng1.
Abstract
This study explored the role and potential molecular mechanism of phillyrin in cerebral ischemia/reperfusion (I/R) injury. The rat middle cerebral artery occlusion (MCAO)/R model was constructed, and cerebral infarction volume, brain water content, and neurological score were measured. Neuron morphological structures in brain tissues and primary neuron apoptosis were detected using hematoxylin and eosin (H&E) staining and Hoechst 33258 staining, respectively. In MCAO/R rats, phillyrin markedly reduced cerebral infarction volume, neurological score, and brain water content and inhibited neuron apoptosis. In vitro experiments showed that phillyrin remarkably increased viability and decreased lactate dehydrogenase (LDH) release of H2O2-injured neurons. Moreover, phillyrin remarkably downregulated the proportion of apoptosis-related protein B-associated X (Bax)/B-cell lymphoma protein 2 (Bcl-2) and reduced procaspase-3, phospho-Akt (p-Akt-1), and phosphorylation-mammalian target of rapamycin (p-mTOR) levels in H2O2-injured neurons. Furthermore, phosphatidylinositol-3 kinase (PI3K) inhibitor ZSTK474 weakened the effects of phillyrin on p-mTOR, p-Akt-1, characteristic proteins of autophagy 3-II (LC3-II) and beclin-1 levels, and H2O2-induced neuronal apoptosis and autophagy. Taken together, phillyrin alleviates I/R injury by inhibiting neuronal cell apoptosis and autophagy pathway, which may provide a new treatment strategy for cerebral I/R injury.Entities:
Keywords: Cerebral ischemic/reperfusion; autophagy; cell apoptosis; oxidative stress; phillyrin
Mesh:
Substances:
Year: 2022 PMID: 35291908 PMCID: PMC9278963 DOI: 10.1080/21655979.2022.2042142
Source DB: PubMed Journal: Bioengineered ISSN: 2165-5979 Impact factor: 6.832
Figure 1.Phillyrin improved the MCAO/R rat brain injury. (a) Schematic diagram of chemical structure of phillyrin. (b) The cerebral infarction analyzed by TTC staining. (c) Percentage of cerebral infarction volume. (d) Neurological deficits of rats. (e) Brain water content of rats. (f) Surviving neuron number in the prefrontal cortex and hippocampus analyzed by H&E staining. (g) Percentage of infarct neurons in prefrontal cortex and hippocampus of rats. Note: n = 6; *P < 0.05 and **P < 0.01 compared with I/R group, ## P < 0.01 compared with the sham group.
Figure 2.Phillyrin improved the activity of primary neurons damaged by H2O2. (a) Cell viability treated with different concentrations of H2O2. (b) Cell viability treated with H2O2 (100 μM) at different time. (c) Effects of phillyrin at different concentrations on H2O2-treated neuron cell viability. (d) Effects of phillyrin with different concentrations on LDH release in H2O2- treated neuron cells. (e) Images of Hoechst staining of neurons and apoptosis rate of neurons in each group. (f, g) Effects of phillyrin with different concentrations on Bax and Bcl-2 expression in H2O2- treated neurons. (h, i) Effects of phillyrin with different concentrations on pro-caspase-3 expression in H2O2- treated neurons. Note: n = 6; *P < 0.05 and **P < 0.01 compared with the H2O2 group; # P < 0.05 and ## P < 0.01 compared with the control group.
Figure 3.Phillyrin promoted Akt-1 phosphorylation in primary neurons. (a) Western blot showing (a) the effects of H2O2 (100 μM) at different treatment time on Akt and p-Akt-1 levels, (b) the effects of phillyrin at different treatment time on Akt and p-Akt-1 levels in H2O2-treated rat cortical neurons, and (c) the effects of phillyrin at different concentrations on Akt and p-Akt-1 levels in H2O2-treated rat cortical neurons. Note: n = 6; #P < 0.05 and ##P < 0.01 compared with control group.
Figure 4.Phillyrin enhanced autophagy of H2O2-treated primary neuron cells. Western blot analysis showing the effects of phillyrin with different concentrations on mTOR (a), LC3 (b), and beclin-1 (c) in H2O2-treated neurons, and (d) the effects of ZSTK474 on the effects of phillyrin in H2O2-treated neurons. (e) LDH release from H2O2-treated neurons with different treatments. Note: n = 6; * P < 0.05 compared with the H2O2 group; **P < 0.01 compared with the H2O2 group; &&P < 0.01 compared with the phillyrin group; ##P < 0.01 compared with the control group.